
Abstract
Objective
Postoperative atrial fibrillation (POAF) is the most common complication after coronary artery bypass grafting (CABG). This study explored the association of coronary sinus (CS) lactate levels with POAF after CABG.
Methods
This was a single-center prospective cohort study of patients without a history of atrial fibrillation undergoing isolated CABG (December 2024 to February 2026). CS lactate was sampled before initiation of cardiopulmonary bypass (pre-CPB), before cross-clamp removal (pre-XC), and after cross-clamp removal (post-XC). POAF was defined as electrocardiogram-documented atrial fibrillation treated with amiodarone during the index hospitalization. Restricted cubic splines were used to define a binary cutoff of post-XC CS lactate at >3 mmol/L. Multivariable logistic regression was performed to assess the association between CS lactate elevation and POAF.
Results
Of the 94 patients included, POAF occurred in 24 patients (26%). Patients with POAF were older and more commonly male but had similar median CPB time and XC duration. Patients with a post-XC lactate >3 mmol/L (n = 13/94, 14%) had significantly greater rates of POAF compared with those without lactate elevation (62% vs 20%, P = .001). After risk adjustment, post-XC lactate >3 mmol/L was associated with a 11.7-fold increase in odds of POAF (P = .010). Increasing age was also linked to greater likelihood of POAF. There was no significant association of POAF with CPB time, XC duration, pre-CPB CS lactate, or pre-XC CS lactate.
Conclusions
Elevated CS lactate after cardiac reperfusion was associated with increased likelihood of POAF. Our findings suggest that CS lactate may be used to guide POAF prophylaxis.
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more